Mycobacterial genomics and structural bioinformatics: opportunities and challenges in drug discovery
Of the more than 190 distinct species of Mycobacterium genus, many are economically and clinically important pathogens of humans or animals. Among those mycobacteria that infect humans, three species namely Mycobacterium tuberculosis (causative agent of tuberculosis), Mycobacterium leprae (causative...
Saved in:
| Main Authors: | Vaishali P. Waman, Sundeep Chaitanya Vedithi, Sherine E. Thomas, Bridget P. Bannerman, Asma Munir, Marcin J. Skwark, Sony Malhotra, Tom L. Blundell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2019-01-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2018.1561158 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Newer initiatives in detection, drug discovery and therapeutic management of drug-resistant tuberculosis
by: Radha Gopalaswamy, et al.
Published: (2024-12-01) -
The role and application of bioinformatics techniques and tools in drug discovery
by: Shujun Zhang, et al.
Published: (2025-02-01) -
Editorial: Multi-target drug discovery and design for complex health disorders
by: Farid A. Badria, et al.
Published: (2025-06-01) -
From Function to Drug Discovery: Insights into Hypothetical Protein Rv1979c from <i>Mycobacterium tuberculosis</i>
by: Mohamed Asif Shajahan, et al.
Published: (2024-04-01) -
Genetics of mycobacterial adaptation to selective pressure of antituberculous compounds dissected at the in vitro and in vivo levels
by: Igor Mokrousov, et al.
Published: (2024-12-01)